Pharmorubicin PFS Interactions
There are 682 drugs known to interact with Pharmorubicin PFS (epirubicin), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 112 are major, 561 are moderate, and 9 are minor.
- View all 682 medications that may interact with Pharmorubicin PFS
- View Pharmorubicin PFS alcohol/food interactions (1)
- View Pharmorubicin PFS disease interactions (5)
Most frequently checked interactions
View interaction reports for Pharmorubicin PFS (epirubicin) and the medicines listed below.
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Baraclude (entecavir)
- BeneFix (coagulation factor ix)
- BeneFix (coagulation factor ix)
- bleomycin
- bleomycin
- Celestone Soluspan (betamethasone)
- Celestone Soluspan (betamethasone)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Cytoxan (cyclophosphamide)
- Cytoxan (cyclophosphamide)
- Doxil (doxorubicin liposomal)
- Doxil (doxorubicin liposomal)
- Etopophos (etoposide)
- Etopophos (etoposide)
- furazolidone
- furazolidone
- Gammagard S/D (immune globulin intravenous)
- Gammagard S/D (immune globulin intravenous)
- Intelence (etravirine)
- Intelence (etravirine)
- Matulane (procarbazine)
- Matulane (procarbazine)
- Megace (megestrol)
- Megace (megestrol)
- mustard
- mustard
Pharmorubicin PFS alcohol/food interactions
There is 1 alcohol/food interaction with Pharmorubicin PFS (epirubicin).
Pharmorubicin PFS disease interactions
There are 5 disease interactions with Pharmorubicin PFS (epirubicin) which include:
Report options
More about Pharmorubicin PFS (epirubicin)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Nolvadex
Nolvadex is used for breast cancer, breast cancer, adjuvant, breast cancer, male, breast cancer ...
Trazimera
Trazimera (trastuzumab-qyyp) is a biosimilar to Herceptin that may be used to treat certain types ...
Nerlynx
Nerlynx (neratinib) is used for the extended adjuvant treatment of early-stage, HER2-positive ...
Soltamox
Soltamox is used for breast cancer, breast cancer, adjuvant, breast cancer, male, breast cancer ...
Paclitaxel
Paclitaxel is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, kaposi's ...
Trastuzumab
Trastuzumab is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.